Posts Currently viewing the category: "Newsletter"

Use Your Social Media to Support GMAN’s International Myeloma Action Day – March 30, 2017 Take action! And inspire other to take action, too! On March 30, the International Myeloma Action Day is an opportunity to spread the word among patients, physicians, and decision-makers to help raise awareness and education about myeloma. Update your…(Read More)

Dear Colleagues, 2017 has had a great beginning! We have entered this year with renewed energy and enthusiasm, and we look forward to a dynamic and productive collaboration with each of you.At the 2016 Annual GMAN Summit in Copenhagen, together we decided to dedicate a day in March as an international Myeloma Action Day…(Read More)

On Friday December 2nd, twenty-five members of the Global Myeloma Action Network (GMAN) and industry partners met in San Diego, California during the annual meeting of the American Society of Hematology (ASH). Members in attendance included Myeloma Canada, Myeloma Australia, MOHA, IMF Latin America and Fundación Colombiana de Leucemia y Linfoma. Nadia Elkebir…(Read More)

​ Myeloma Canada Launches Database On September 1, Myeloma Canada officially launched the Myeloma Canada Research Network National Multiple Myeloma Database. A first of its kind in Canada, “the Database is a key stepping stone to finding a cure” said Dr. Reece, Chair, Multiple Myeloma Clinical Trials Group of the Canadian Cancer Trials Group, and…(Read More)

  Cancer Moonshot Establishes Five Strategic Goals On October 17th, US Vice President Joe Biden released his report from the Cancer Moonshot Task Force with recommendations on objectives for the initiative. We previously reported on the activities of the Task Force and the Blue Ribbon Panel in last month’s newsletter as both groups continued…(Read More)

  US Cancer Moonshot Blue Ribbon Panel Unveils Its 10 Recommendations On September 7, 2016, a Blue Ribbon Panel—an offshoot of Vice President Joe Biden’s Cancer Moonshot initiative—held a conference and announced its 10 Recommendations. These recommendations focus on seven main areas: clinical trials, better and greater data-sharing, cancer immunology, pediatric…(Read More)

Vol.2 Issue 8 August  2016   New Format for GMAN Newsletter Coming Soon Next month, changes will occur to the GMAN newsletter that will make it more accessible for our members. The format will be altered and new sections will be added that readers should find interesting and useful. We sincerely…(Read More)

Vol.2 Issue 7 July  2016   New Austrian Patient Education Tool Doctors Iris Herscovici and Anita Hoerburger, in collaboration with Myeloma and Lymphoma Aid Austria, have developed a new patient education tool for those diagnosed with myeloma or lymphoma. Within the tool, information is provided for patients who have been recently…(Read More)

Vol.2 Issue 6 June  2016   GMAN Summit 2016 – Copenhagen, Denmark This year GMAN’s 4th annual summit was held in Copenhagen, Denmark. We had wonderful participation from our members with 40 individuals representing 30 organizations and 25 countries from all over the world. Members from as far as Australia, South…(Read More)

Vol.2 Issue 5 May  2016   GMAN Webinar on Recent FDA-Approved Myeloma Drugs Did you miss the recent GMAN webinar on newly approved myeloma drugs? On Friday May 13th, Dr. Rafat Abonour of Indiana University presented on each of the newly approved drugs, how they were developed, how they operate…(Read More)